JNC is using BioProcess International 2026 to spotlight Cellufine and its emerging MLP chromatography media, developed to address purification challenges posed by viral vectors, vaccines, and other increasingly large and complex biological products.
JNC is using BioProcess International 2026 to spotlight Cellufine and its emerging MLP chromatography media, developed to address purification challenges posed by viral vectors, vaccines, and other...
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
JNC is using BioProcess International 2026 to spotlight Cellufine and its emerging MLP chromatography media, developed to address purification challenges posed by viral vectors, vaccines, and other increasingly large and complex biological products.
JNC is using BioProcess International 2026 to spotlight Cellufine and its emerging MLP chromatography media, developed to address purification challenges posed by viral vectors, vaccines, and other increasingly large and complex biological products.
Open the app view to save this story, compare related coverage, and continue from the same source.